Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A few small human trials have been conducted, primarily for inflammatory bowel disease
Monitoring Response Patients or research participants typically notice: Appetite suppression within the first 12 weeks Early satiety and slower gastric emptying by weeks 34 Weight loss trends becoming evident by week 8 Continued improvements in glucose metabolism when paired with semaglutide or tirzepatide Side Effects and Considerations Common side effects include: Nausea Mild gastrointestinal discomfort Constipation Injection site reactions These effects are generally transient and dose-dependent, which is why titration is important
Delivery timelines, payment methods, and international shipping availability follow the policies described on our shipping and payments page, please note that shipping depends on current laws and logistical environment
So it's a great product to have it, but in moderation
